High profile endorsement for Dr. David Moher’s clinical trial reporting guideline

February 12, 2014

Writing in the journal Nature, two leaders of the U.S. National Institutes of Health (NIH) have commended the clinical trials community for taking “important steps towards adopting standard reporting elements” developed by Dr. David Moher and his colleagues (called the CONSORT statement). The commentary, written by Drs. Francis Collins and Lawrence Tabak, outlines the NIH’s efforts to enhance the reproducibility of preclinical research.

About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.

Media contact
Jennifer Ganton
Director, Communications and Public Relations
Ottawa Hospital Research Institute
613-798-5555 x 73325
613-614-5253 (cell)